L-BMAA hydrochloride

CAS No. 16012-55-8

L-BMAA hydrochloride( β-N-methylamino-L-alanine hydrochloride )

Catalog No. M23698 CAS No. 16012-55-8

L-BMAA hydrochloride is a neurotoxin produced by cyanobacteria.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 48 In Stock
25MG 75 In Stock
50MG 100 In Stock
100MG 160 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    L-BMAA hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    L-BMAA hydrochloride is a neurotoxin produced by cyanobacteria.
  • Description
    L-BMAA hydrochloride is a neurotoxin produced by cyanobacteria. L-BMAA hydrochloride could cause amyotrophic lateral sclerosis (ALS) and possibly other neurodegenerative diseases.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    β-N-methylamino-L-alanine hydrochloride
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    16012-55-8
  • Formula Weight
    154.6
  • Molecular Formula
    C4H11ClN2O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:Soluble
  • SMILES
    N[C@@H](CNC)C(O)=O.[H]Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Caller T, et, al. The Potential Role of BMAA in Neurodegeneration. Neurotox Res. 2018 Jan; 33(1): 222-226.
molnova catalog
related products
  • 4-methylnonan-5-ol

    4-methylnonan-5-ol is a pheromone of red palm weevils and can be used to capture red palm weevils and reduce their harm to agriculture.

  • L-m-Tyrosine

    L-(-)-m-Tyrosine is a non-natural amino acid. L-(-)-m-Tyrosine displays the potential in treating Parkinson's disease, arthritis, and Alzheimer's disease.

  • Mitazalimab

    Mitazalimab (ADC-1013; JNJ-64457107) is an FcγR-dependent CD40 agonist that targets tumors by activating antigen-presenting cells like dendritic cells (DC), initiating tumor-reactive T cells, promoting tumor-specific T cell infiltration and destruction of tumors, and remodeling the tumor-infiltrating myeloid microenvironment .